Indeed, we found that high expression of a set of genes in IL11FS, but not IL11 or signature genes of IAFs (IL11/IL24/IL13A2/TNFRSF11B), was associated with reduced recurrence-free survival duration in CRC patients. The gene discussed is IL24; the disease is colorectal carcinoma.